Company intelligence / Profile preview

UnifAI Technology

London, United Kingdomunifaitechnology.com ↗

Ownership: Private
Employees: ~3
Development stage: Other

Overview

UnifAI Technology provides cloud-based AI solutions that turn smartphones into medical devices for accurate reading of lateral flow diagnostic tests. They are the sole provider of this technology to the UK Health Security Agency's Test & Trace Programme. The company also collaborates with innovative medtech startups on non-invasive blood glucose monitoring and next-generation bioelectrical therapeutics.

Therapeutic areas: OtherEndocrinologyInfectious Diseases
Modalities: DeviceDigital diagnostic toolArtificial intelligence platform
Industry: Digital Health Medical Devices

Partnerships

UK Health Security AgencyAfon TechnologyNuroKor BioelectronicsWessex WaterBritish Standards Institution

Beyond the preview

Go deeper on UnifAI Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UnifAI Technology.

Explore the full profile